Related Experiment Video

Updated: May 25, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

Neurobehavioral consequences of prenatal antiepileptic drug exposure

Caroline Nadebaum1, Vicki Anderson, Frank Vajda

  • 1School of Psychology and Psychiatry, Monash University, Melbourne, Australia.

Developmental Neuropsychology
|February 2, 2012
PubMed

Insights

Prenatal antiepileptic drug exposure may increase risks for birth defects and cognitive issues. Further research is needed to understand long-term neurobehavioral effects for pregnant women with epilepsy.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Teratology

Background:

  • Antiepileptic drug (AED) pharmacotherapy is often continued during pregnancy due to seizure risks.
  • Prenatal AED exposure is linked to birth defects.
  • Emerging evidence suggests potential cognitive impairment risks with prenatal valproate or polytherapy.

Purpose of the Study:

  • To investigate the incomplete understanding of longer-term neurobehavioral consequences of prenatal AED exposure.
  • To provide accurate information for women with epilepsy planning pregnancy.
  • To optimize outcomes for mothers and children affected by prenatal AED exposure.

Main Methods:

  • This study synthesizes existing data on neurodevelopmental outcomes following prenatal AED exposure.
  • Longitudinal studies and meta-analyses are reviewed.
  • Specific AEDs and polytherapy regimens are considered.

Main Results:

  • Prenatal AED exposure is associated with an increased risk of birth defects.
  • Cognitive impairments may be linked to specific AEDs like valproate and polytherapy.
  • Long-term neurobehavioral sequelae require further comprehensive investigation.

Conclusions:

  • Understanding the full spectrum of neurobehavioral effects from prenatal AED exposure is critical.
  • Informed decision-making for pregnant women with epilepsy requires comprehensive data.
  • Optimizing maternal and child health necessitates continued research into AEDs in pregnancy.

More Related Videos

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants07:08

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants

Published on: March 6, 2018

Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development15:27

Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development

Published on: July 13, 2014

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...